Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

Pfizer

Status: Completed

Conditions: Arthritis, Rheumatoid

Treatments: Drug: CP-690,550

Study type: Observational

Funder types: Industry

Identifiers

NCT00414661

A3921029

Details and patient eligibility

About

The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for this study after they have completed all participation in other studies of CP-690,550.

Full description

At their last visit of a qualifying study, eligible subjects will be given the opportunity to participate in this study.

Enrollment: 162 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who have completed all participation in any other Phase 2B or Phase 3 studies of CP-690,550 for rheumatoid arthritis.

Exclusion criteria

• Any subject who refuses consent.

Trial design

162 participants in 1 patient group

Study group

Description:

All enrolled subjects

Treatment:

Drug: CP-690,550